Stock BTCY BIOTRICITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biotricity, Inc.

Equities

BTCY

US09074H2031

Delayed Nasdaq
Other stock markets
 12:04:21 30/04/2024 am IST 		5-day change 1st Jan Change
1.29 USD +0.78% Intraday chart for Biotricity, Inc. -11.64% +12.17%
26/04 Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro CI
19/04 Top Premarket Decliners MT

Evolution of the average Target Price on Biotricity, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d91ef76ee4a96488dcbd.c_o4qj_X7UZnCTZdGjWEE8voiChokziqvXqr7jEAMDI.IrIPxBKWgDEKfV5rK2_TUb6Ev14YwEnAxB7Rn3BpQ3kZqQ_bCp-pFCJKAg~fcc340db7ae34cc00c9974430742c47b

Analyst Recommendations on Biotricity, Inc.

HC Wainwright Downgrades Biotricity to Neutral From Buy MT
HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating MT
HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating MT
Biotricity Exceeds $10 Million in Annual Revenue Run Rate MT
Maxim Downgrades Biotricity to Hold From Buy MT
Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating MT
HC Wainwright Adjusts Biotricity's Price Target to $2 from $6, Keeps Buy Rating MT
Lake Street Starts Biotricity at Buy With $5 Price Target MT
HC Wainwright Starts Biotricity at Buy With $6 Price Target MT
Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications CI
Rockyview General Hospital Leverages biotricity’s Remote Monitoring Technology to Track Heart Rate Variability and Predict Health Outcomes CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.28
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biotricity, Inc.

HC Wainwright
Lake Street
Maxim

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTCY Stock
  4. Consensus Biotricity, Inc.